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Objectives
. This study was undertaken t' differentiate hyper ,
trophic cardiomyopathy from hypertensive hypertrophy using a
newly developed M-mode format integrated backscatter imaging
system capable of calibrating myocardial integrated backscatter
with the power of Doppler signals from the blood .
Back groraard Myocardial integrated ultrasound backscatler
chanes in patients with hypertrophic cardiomyopathy ; however,
It is unknown whether ultrasound myocardial tissue characteriza-
tion may be useful In differentiating hypertrophiccardiomyopathy
from hyperteasive hypertrophy-
Methods. Calibrated myocardial Integrated backscatter and its
tr rural gradient were measured in the septum and posterior
wall to 31 normal subjects, 13 patients with hypertensioe hyper-
trophy and 22 patients with bypertrophic cardiomyopathy . The
gradient in Integrated backscatter was determined as the ratio or
calibrated integrated backscatter in the endocardial half to that in
the eplcardlal half of the myocardium .
In addition to the pathologic ventricular hypertrophy seen in
patients with hypertrophic cardiomyopathy, ventricular hy-
pertrophy may develop physiologically in patients with
hypertension, as an adaptive process to pressure overload
(1,2) . Although conventional echocardiography is particu-
larly useful ir1 detecting increased left ventricular mass or
abnormal myocardial function, or both, in patients with
possible ventricular hypertrophy (3-8), the two entities are
most clearly differentiated by detection of the presence of
myocardial fiber architecture distortion or extremely in-
creased collagen (9-14) . Thus, one of the goals of myocar-
dial tissue characterization is to distinguish pathologic from
physiologic hypertrophy . 1nis may become possible because
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Resuhs. Cyclic variation of integrated backscatter was smaller
and calibrated myocardial integrated backscatter higher In pa-
tients with hypertrophied hearts than in normal subjects, but
there were no significant differences in either integrated backscat-
ter measure between patients with hypertensive hypertrophy and
those with hypertrophic car iomyopathy . Transmural gradient in
myocardial integrated backacatter was present only in patients
with hypertrophic cardlomyopathy (5 .0 * 1 .8 dB (mean ± SDI for
the septum ; 1 .2 ± 1 .6 dB for the posterior wall) .
Cor®ciusioas
. Hypertrophic cardiomyopathy and
ventricular
hypertrophy due to hypertension can be differentiated on the basis
of quantitative analysis of the transmural gradient in integrated
backscatter.
(J Am Coil C ioi 1994;24:517-24)
a number of experimental studies have shown that measure-
ments of integrated ultrasonic backscatter are useful in
detecting physiologic and pathologic changes in the myocar-
dium (15-24) .
Myocardial tissue characterization in human hypertro-
phied hearts has been attempted by a few groups (25-30) .
They clearly showed the difference in ultrasonic tissue
variables between hypertrophied and normal hearts ; how-
ever, it has not been documented whether ultrasound tissue
backscatter can distinguish between hypertrophic cardiomy-
opathy and ventricular hypertrophy due to hypertension .
In this study, we measured acoustic properties of the
myocardium in patients with hypertrophied hearts to clarify
whether any integrated backscatter measure may be useful
in distinguishing between hypertrophic cardiomyopathy and
ventricular hypertrophy due to hypertension . Therefore,
calibrated myocardial integrated backscatter was measured
using a newly developed M-mode format integrated back-
scatter imaging system capable of calibrating myocardial
integrated backscatter with the power of Doppler signals
from the blood. We also analyzed the transmural trend of the
acoustic properties of the myocardium .
0735-10971941$7.00
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Methods
Ultrasound backscatter instrumentation . The integrated
backscatter imaging system consisted of a commercially
available echocardiograph (ME-130A, Fujitsu Co .) with a
3.5-MHz frequency transducer, analogldigital converter and
personal computer system (FMR-SOHLI, Fujitsu Co.) . Un-
like a conventional imaging system, the ultrasound signals
were accessed with the integrated backscatter processor to
produce a continuous signal that is proportional to the loga-
rithm of integrated backscatter. In this study, myocardial
integrated backscatter was calibrated by the backscatter
power from the blood . To correct for the attenuation or
signal loss resulting from transmission through intervening
tissue between the transducer and Doppler sample volume,
the logarithmic power of Doppler signals scattering from the
blood was subtracted from the logarithmic power at the area
of interest in the myocardium . In this study Doppler sample
volume was positioned just below the septum in the left
ventricular cavity, and the area of interest for tissue charac-
terization was positioned in the septum or posterior wall
along the same interrogated beam . Characteristics of the
transducer and system were adjusted beforehand using a
dextran particle suspension of the known backscatter coef-
ficient so that we could compare the amplitudes of ultra-
sound backscatter from the areas of interest with different
depths .
Subjects. Thirty-eight patients with hypertrophied hearts
were considered for this study . Three were excluded be-
cause integrated backscatter images of adequate quality
could not be obtained . Therefore, the study group included
35 patients with hypertrophied hearts (29 men, 6 women ;
mean e 55 years, range 14 to 80 years) . The etiology of
hypertrophied hearts was considered to be hypertension in
13 patients and hypertrophic cardiomyopathy in 22 . The
diagnosis of hypertrophic cardiomyopathy was based on the
presence of a hypertrophied, nondilated left ventricle with-
out a clinically defined cause. In 16 of the 22 patients with
hypertrophic cardiomyopathy, asymmetric septal hypertro-
phy (septal/free wall thickness ratio atI .3) was present on
M-mode echocardiograms . In 9 of the 22 patients with
hypertrophic cardiomyopathy, an intracavitary pressure gra-
dient, assessed with continuous wave Doppler echocardiog-
raphy, was >16 mm Hg at rest, Thirty-one normal subjects
(20 men, 11 women ; mean age 55 years, range 25 to 70)
served as control subjects . Before the integrated backscatter
studies, all subjects were examined using conventional two-
dimensional and M-mode echocardiography to assess cham-
ber size, wall thickness and wall motion (Table 1) . Echocar-
diographie variables were measured in a standard manner
from parasternal views (31) .
Data analysis
. The integrated backscatter study was per-
formed without any knowledge of patient characteristics by
monitoring the two-dimensional echocardiographic image
with an interrogated beam and Doppler sample volume in the
right half of the display and an M-mode echocardiogram in
Table 1 . Echocardiographic and Integrated Backscatter Variables
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"'p
< 0.05 versus normal subjects . tp < 0
.01 versus normal subjects . I p
<
0.01 versus subjects with hypertensive hearts
. Data presented are mean value
± SD. Calibrated 1B = maximal integrated backscatter at and-diastole ; F =
female; FS = fractional shortening
; LVI) = left ventricular dimension ; M =
male; PW = posterior wall
; Variation IB = magnitude of cardiac cyclic
variation of integrated backscatter.
the left half. The Doppler spectrum was monitored only by
sound, not on the display . Once the toggle switch was turned
to the "on" position, radiofrequency signals were converted
to digital ones, and data longer than -5 s were stored in the
computer memory . The integrated backscatter images were
then reconstructed by the personal computer system using
the stored data. On the monitor, the area of interest for
backscatter measurements was traced midway between the
endocardial and epicardial borders in the septum and poste-
rior wall. We tried to exclude the thick bright lines of the
endocardium and intramyocardial specular bright echoes
from the area of interest . The depth of this area was 5 mm ;
the trace of the center of it is indicated by a bright line .
To calibrate myocardial integrated backscatter, we deter-
mined the power of Doppler signals sampled in the left
ventricular cavity as follows . The depth of the sample
volume was 7 mm. In the Doppler power spectrum displayed
on the computer screen, we selected by hand the intervals
when signals were considered adequate for calculating
Doppler power. The Doppler power averaged over the
selected intervals was used for calibrating myocardial inte-
grated backscatter. It is noteworthy that strong signals
considered to have originated from the structure movement
are eliminated automatically by the computer program . In
addition, the power of Doppler signals does not vary instan-
Normal
Subjects
to = 31)
Hypertensive
Heart
(n = 13)
Hypertrophic
Cardioroyopathy
(n = 22)
Age (yr) 46 ± 13 59 ± 8° 54 a 17
Gender (R+t/F) 2(>/! I 914 2012
Calibrated IB
Septum (dB) 42 .0 a 4 .2 47,9 t 2 .6t 47 .9 a 2 .9t
PW (0) 31 .1 ± 5 .3 38 .8 s 2 .8t 38 .0 ± 5 .7t
Variation 103
Septum (dn) 7 .7 ± 1 .1 4 .7
a
0 .6t 5 .0 ± Lit
PW (d8) 7 .7 ± 1 .1 4 .8 ± 0 .5t 5 .2 ± Lot
LVD (mm)
End-diastole 47 ± 4 47 ± 5 45 ± 7
End-systole 28 ± 4 27 ± 7 26 2 7
FS (%) 40 ± 5 43 ± 10 41 ± l2
Scptal thickness (mm)
End-diastole 9 °s° 1 15 121 19 ± 4t):
End-systole 13 ± 2 20
a
4t 22 ± 4t
Posterior wall
thickness (mm)
End-diastole 8 a 1 13 ± 2f 13 a 4t
End-systole 14 ± 2 20 ± 4t 20 a 4t
% Systolic thickening
Septum 56 ± 22 28 a 17t 16 ± 10t
Posterior wall 74 ± 26 52 a 21 62 a 31
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taneously . Thus, one may use the averaged Doppler power
for calibrating myocardial integrated backscatter even at
different instances if the ultrasound beam direction is con-
stant .
After placing t ;i : area of interest for backscaiter measure-
ments in the M-mode integrated backscatter images and
selecting time intervals with adequate Doppler signals in the
Doppler image, the computer screen shows curves of myo-
cardial integrated backscatter calibrated by the power of the
Doppler signals . From these curves, we consistently mea-
sured two variables in all subjects . The magnitude of cyclic
variation in integrated backscatter was determined as the
difference between minimal and maximal peaks . The value
of myocardial integrated backscatter at maximal peak was
defined as the calibrated myocardial integrated backscatter
at end-diastole. Averaged values over at least 3 beats were
provided for quantitative analysis . Both variables are essen-
tially independent of the transmitted ultrasound power and
attenuation by the chest wall and therefore may be compared
among subjects .
In addition to the averaged value of myocardial integrated
backscatter in the area of interest, our system provides the
values of myocardial integrated backscatter of the upper and
lower halves in the area of interest . This function was used
to assess the transmural trend in the measures of myocardial
integrated backscatter (gradient integrated backscatter) in
21 normal subjects and in all patients with hypertrophied
hearts .
Reproducibility. Interobserver and intraobserver vari-
abilities of the measurements of the integrated backscatter
variables were studied . Integrated backscatter measures
were determined on screen, and variability was therefore
assessed as follows. M-mode integrated backscatter images
were obtained in 12 subjects by one observer . Two observ-
ers independently analyzed the integrated backscatter im-
ages to determine their variables . These were compared for
determination of interobserver variability . Intraobserver vari-
ability was determined by one observer repeating the analysis
process a second time in these 12 subjects for comparison with
the first measurements . Mean (±SD) absolute differences of
the magnitude of cyclic variation of integrated backscatter
between observations were 0.7 ± 0.4 dB (interobserver) and
0.6 ± 0.4 dB (intraobserver) for the septum and 0 .8 ± 0.3 dB
(interobserver) and 0 .5 ± 0.4 dB (intraobserver) for the
posterior wall. Mean absolute differences of the calibrated
integrated backscatter at end-diastole between observations
were 0.8 ± 0.4 dB (interobserver) and 0 .6 ± 0.3 dB (intra-
observer) for the septum and 0 .7 ± 0.4 dB (interobserver)
and 0.5 ± 0.4 dB (intraobserver) for the posterior wall .
Absolute differences of the regional calibrated integrated
backscatter at end-diastole between observations were 0
.7 ±
0.4 dB (interobserver) and 0 .6 ± 0.3 dB (intraobserver) for
the septum and 0.7 ± 0.5 dB (interobserver) and 0.5
± 0.4 dB
(intraobserver) for the posterior wall .
Statistical analysis . Data are presented as mean value
SID. Intergroup differences were tested for significance using
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Figure 1 . Curves of myocardial integrated backscatter (1B) versus
time in the septum (upper panels) and posterior wall (HO (lower
panels) in a normal subject (a), a patient with ventricular hyper-
trophy due to hypertension (b) and a patient with hypertrophic card-
iomyopathy (c) . The magnitude of cardiac cyclic: variation of
integrated backscatter was smaller, and calibrated myocardial inte-
grated backscatter greater, in patients with hypertrophied hearts
than in normal subjects . There was no difference in either integrated
backscatter measure between the patient with ventricular hypertro-
phy due to hypertension and the patient with hypertrophic cardio-
myopathy . Measurements of the magnitude of cardiac cyclic varia-
tion of integrated backscatter and calibrated myocardial integrated
backscatter are shown by thin (left) and thick (right) white arrows,
respectively, in the upper left panel .
analysis of variance, with subgroup analysis by the Scheffd
F test. Relations between two variables were studied using a
simple linear regression analysis .
Results
Integrated backscatter measures in normal subjects and
patients with hypertrophied hearts . The magnitude of cyclic
variation in integrated backscatter was significantly smaller
and calibrated myocardial integrated backscatter signifi-
cantly greater in patients with hypertrophied hearts than in
normal subjects. There was no difference in either measure
between patients with ventricular hypertrophy due to hyper-
tension and those with hypertrophic cardiomyopathy (Fig . 1,
Table 1) .
Transmural trend of integrated backscatter measures .
The magnitude of cyclic variation in integrated backscatter
did not differ between the right and left ventricular halves of
the septum or between the endocardial and epicardial halves
of the posterior wall in all normal subjects and all patients
with hypertrophy (Fig . 2, Table 2) . There was no significant
difference in the calibrated myocardial integrated backscat-
ter between the right and left ventricular halves of the
septum or between the endocardial and epicardial halves of
511)
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F%m 2. Curves of myocardial integrated backscatter (113) versus
time in the left ventricular endocardial half (LV [endol half, and the
right ventricular epicardial half (RV [epi] half) of the septum (upper
powls)
am' in the endocardial half (endo half) and epicardial half (epi
half) of the posterior wall (PW) (lower
panels) in a patient with
hypertensivae hypertrophy (a) and in a patient with hypertrophic
cardiomyopathy
(h).
There was no difference in the magnitude of
cardiac cyclic variation of integrated backscatter between the right
and left ventricular halves or between the endocardial and epicardial
halves in both patients
. In contrast, calibrated myocardial integrated
backscaUer was significantly greater in the right ventricular epicar-
dial half than in the left ventricular endocardial half of the septum
only in the patient with hypertrophic cardiomyopathy
(b) .
do) half RV
endo half epi half
LV (endo) half RV
X
I
P5*R
.Y>
pi) hail
.
rz
pi) h If
Table 2 . Transmural Trend in Integrated Backscatter Measures
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'p < 0.01 versus normal subjects . tp < 0.01 versus left ventricular half in
septum or endocardial half in posterior wall. t p < 0.05 versus normal
subjects . §P < 0 .01 versus hypertensive hearts. lip < 0 .05 versus hypertensive
hearts
. Data presented are mean values ± SD
. Endo-half = eadocardial half
in posterior wall
(PW) ;
Epi-half = epicardial half in posterior wall, Gradient
1B = transmural gradient in integrated backscatter, LV .half = left ventricular
half in septum ; RV-half = right ventricular half in septum . other abbreviations
as in Table I .
the posterior wall in normal subjects and patients with
ventricular hypertrophy due to hypertension . In contrast,
calibrated myocardial integrated backscatter was signifi-
cantly greater in the right ventricular than in the left ventric-
ular half of the septum and in the epicardial than in the
endocardial half of the posterior wall, respectively, in pa-
tients with hypcrtrophic cardiomyopathy .
The transmrral trend of the calibrated myocardial inte-
grated backscatter was quantified by calculating the differ-
ence in decibels between subendocardial and subepicardial
regions . Subtracting the logarithmic decibel domain is equiv-
alent to taking a ratio in the linear domain ; therefore our
variables express the ratio of calibrated myocardial inte-
grated backscatter in the left ventricular (endocardial) half to
that in the right ventricular (epicardial) half for the septum,
and the ratio of calibrated myocardial integrated backscatter
in the endocardial half to that in the epicardial half for the
posterior wall. The transmural gradient in integrated back-
scatter was significantly greater in patients with hypertro-
phic cardiomyopathy than in normal subjects and in patients
with ventricular hypertrophy due to hypertension in both the
septum and posterior wall (Fig . 3).
Transmurall gradient in integrated backscatter and
eclaocardk1pip4h4c variables . The transmural gradient in in-
tegrated backscatter was compared with ventricular wall
thickness (Fig . 4) . It is again noteworthy that the transmural
gradient in integrated backscatter was not observed in nor-
mal subjects and in patients with ventricular hypertrophy
due to hypertension . Most patients with hypertrophic car-
Normal
Subjects
In =
21)
Hypertensive
Heart
(n = 13)
Hypettrophic
Caidiomyopathy
(n = 22)
Arge (yr)
44 :t 10 59!!! P 54 ± 17
Gender (MIF)
Calibrated 18 (dB)
1517 914 2012
RV-half
LV-half
42 .5 :t 3 .9
42 .4 ± 3 .8
48.0 ± 2 .68
47.8 ± 20
50 .8 ± 4 .1
45 .7 ± 4
.2t
Epi-half 30.8 ± 5 .6 38 .8 ± 2 .7* 38 .6 ± 6.0*t
Endo-half
Variation 1B (dB}
30
.7 ± 5 .7 38.7 ± 2.7* 37,4 :t 5 .6*
RV-half
7 .7 ± 1 .1 V OV 5.0 1 .1*
Lv.half 7 .7 ± 1 .1 4.7 0.6' 5,0 I'll
Epi-half 7 .9 i 1 .2 4.8 M0 53 1 .0*
Endo-half
Gradient 1B (dil)
7 .9 ± 1
.1
4.9 0.5 11 5 .2
1
.0'
Septum
O .I ± 0 .2
0.2 0.3 5.0 1-84
PW 011±0 .2 0.1±0.3 1.2±1.60 11
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Figure 3 . Comparison of transmuril gradient in integrated backscat-
ter (113) among normal subjects, patients with ventricular hyper-
trophy due to hyperlensio., (HT) and patients with hypertrophic
cardiomyopathy (11CM) in the septum (left) and posterior wall (PW)
(right) . Transmural integrated backscatter gradient was significantly
greater in patients with hypertrophic cardiamyopathy than in normal
subjects and patients with ventricular hypertrophy due to hyperten-
sion . but there was no significant difference in this measure between
normal subjects and patients with ventricular hypertrophy due to
hypertension in both the septum and the posterior wall .
diomyopathy showed a positive transmural gradient in inte-
grated backscalter in the septum, but only about half of them
showed a positive transmural gradient in integrated back-
scatter in the posterior wall . Furthermore, the gradient was
smaller in the posterior wall than in the septum (p < 0 .01). It
was observed that there was no significant correlation be-
tween the transmural gradient in integrated backscatter and
wall thickness in patients with hypertrophic cardiomyopathy
(r = 0.12, p = NS for the septum ; r = 0 .20, p = NS for the
posterior wall) .
Figure 4 . Relation between wall thickness and transmural gradient
in integrated backscatter in the septum and posterior wall . Abbre-
viations as in Figure 3 . See text for explanation .
Septum
a
o 140"TIA
A mr
a Hem
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Discussio
Several experimental studies (15-22) support the idea that
both the absolute integrated backscatter and the magnitude
of the cardiac cycle-dependent variation of integrated back-
scatter reflect the acoustic properties of the myocardium,
becauic absoluke integrated backscatter increases in myo-
cardial fibrosis (15.-17) and the magnitude of the cardiac
cycle-dependent variation of integrated backscatter has been
demonstrated to decrease with myocardial ischemia and
infarction (19-22)
. Such changes in integrated backscatter
measures were observed in patients with hypertrophied
hearts ; however, there was no difference in either measure
between ventricular hypertrophy due to hypertension and
hypertrophic cardiomyopathy . Thus, we failed to distinguish
between ventricular hypertrophy due to hypertension and
hypertrophic cardiomyopathy by using these integrated
backscatter measures. In contrast, myocardial integrated
backscatter was greater in the right ventricular half than in
the left ventricular half in the septum only in patients with
hypertraphic cardiomyopathy, and the measurement of the
transmural trend of integrated backscatter was useful in
distinguishing between ventricular hypertrophy due to hy-
pertension and hypertrophic cardiomyopathy .
Ventricular hypertrophy due to hypertension . This study
showed that calibrated myocardial integrated backscatter
increased significantly in patients with ventricular hypertro-
phy due to hypertension . Tanaka et al . (14) indicated that the
percent area of fibrosis in the left ventricular wall was
greater in hypertensive heart disease than in normal hearts .
Myocardial fibrosis increases absolute integrated backscat-
ter in both in vitro and in vivo experiments (15-17,32), and
thus the possible structural changes of an increase in fibrosis
of the myocardium may account for the increase in cali-
brated integrated backscatter in our patients with ventricular
hypertrophy due to hypertension .
Cyclic variation in integrated backscatter was signifi-
cantly smaller in patients with ventricular hypertrophy due
to hypertension than in normal subjects . This finding is
consistent with our previous finding (28). The mechanism for
this phenomenon is still unknown, but reduced regional
myocardial contractile function may be the most likely
explanation because the dependence of the magnitude of
cardiac cyclic variation of integrated backscatter on contrac-
tile performance has been documented in experimental stud-
ies (33-36) . Furthermore, regional myocardial contractile
function assessed with percent systolic wall thickening was
depressed in our patients with ventricular hypertrophy due
to hypertension .
rRypertruphic cardioyopaft- In this study, calibrated
integrated backscatter increased significantly, and the mag-
nitude of cyclic variation in integrated backscatter decreased
significantly, in patients with hypertrophic cardiomyopathy
compared with normal subjects . This finding is consistent
with our previous findings and those of Lattanzi et at .
(28-30) . The changes in integrated backscatter measures
(dB Septum (da) Pt1V
10 16-
LM LB
2 2 -2-i -0s
4-
1
c
I M
2
is
2
ows
WE
normW HT 11CM HT la ; t®
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were not different from those observed in patients with
ventricular hypertrophy due to hypertension, and the mech-
anism may also be the same (i .e .,
myocardial fibrosis and
regional myocardial contractile function)
. Although myocar-
dial fibrosis is usually more severe in hypertrophic cardio-
myopathy than in ventricular hypertrophy due to hyperten-
sion, the changes in the integrated backscatter measures
were not different between these subsets
. This finding sug-
gests the possible effects of myocardial cell disor nization
on these integrated backscatter measures in patients with
hypertrophic cardiomyopathy . Although both integrated
backscater measures failed to distinguish between hypertro-
phic c :=. ; liomyopathy and ventricular hypertrophy due to
hyperW ;,Jon in th present study, we stili believe that both
inte led backscatter measures are useful to assess ventric-
ular hypertrophy, partially because Lattanzi and colleagues
showed that myocardial integrated backscatter was normal
in subjects (elite athletes) with physiologic ventricular hyper-
trophy caused by intense physical training (301 .
T trend in acoustic properties of the myocar-
dium, The distinction between hypertrophic cardiomyopa-
thy and ventricular hypertrophy due to hypertension was
possible only with the measurements of transmural trend of
integrated backscatter in our patients with hypo trophy .
Transmural gradient in integrated backscatter was observed
only in patients with hypertrophic cardiomyopathy . Fuji-
wara et al . (37) conducted histologic studies on autopsied
human hearts to show that myocardial fiber disarray in
patients with hypertrophic cardiomyopathy was present
mostly in the middle third of the septum and in the middle
and outer thirds of the posterior wall . If myocardial fiber
disarray worked to increase integrated backscatter,
the
observed transmural gradient of integrated backscatter
might be explained as the effect of the transmural nonhomo-
geneity of myocardial fiber disarray . The transmural gradient
of integrated backscatter measure was obviously larger and
more frequent in the septum than in the posterior wall in
patients with hypertrophic eardiomyopathy. This finding
may be also explained by the effect of the transmural non-
homogeneity of myocardial fiber disarray because this dis-
array is more extensive in the septum than in the posterior
wall (37-39).
The transmural gradient in integrated backscatter did not
correlate with wall thickness in patients with hypertrophic
cardiomyopathy either in the septum or posterior wall .
Further, the transmural gradient in integrated backscatter
was not observed even in patients with advanced hypertro-
phy due to hypertension . These findings are in contrast to
the previous finding that the magnitude of variation of
integrated backscatter decreases as wall thickness increases
in patients with pressure overload hypertrophy, hypertro-
phic cardiomyopathy and cardiac transplants (28,40) . Thus,
assessment of the transmural gradient in integrated back-
scatter is likely to expand the use of myocardial ultrasound
tissue characterization in patients with hypertrophied hearts .
The abnormal acoustic properties of the myocardium may be
!ACC Vol. 24, No. 2
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an expression of the intrinsic myopathic process. Thus, our
findings support the hypothesis that the intrinsic myopathic
process involves the myocardium in a transmurally nonho-
mogeneous fashion, even in nonhypertrophied segments of
the wall. This hypothesis is consistent with the previous
findings that histologic abnormalities are observed even in
segments of the wall with normal or minimally hypertrophied
thickness (38,41-43) .
Integrated bac tier in the septum versus i i, tenor wall.
The present study showed the significant regional differences
in calibrated myocardial integrated backscatter between the
septum and posterior wall in patients with hypertrophied
hearts and in normal subjects. This finding is comparable
wiO those obtained by other investigators (29,44,45) . It may
be explained by the techniques used in the determination of
integrated backscatter measures and thus was observed in all
subjects. Alternatively, regional differences in muscle fiber
orientation may account for regional differences in acoustic
properties (44) . Regional myocardial contractile function
appears to be a less significant contributor to the calibrated
myocardial integrated backscatter than to the magnitude of
cyclic variation in integrated backscatter (28) because this
measure is unaffected by an alteration of cardiac function in
dogs (unpublished observations) . To exclude the possible
effects of the regionality of myocardial integrated backscat-
ter measures on the results of this study, the septum and
posterior wall were analyzed separately .
Cyclic variation in integrated backscatter was slightly
greater in this study than in most previous ones (46-48) . The
reason for this could not be clarified but may be related to
the system used . We consider this likely because in our
system, integrated backscatter was determined using band-
limited rather than broad-band frequency ultrasound signals .
Technical limitations. Four technical limitations are
noted. First, technically adequate integrated backscatter
images were not obtained in 3 of 38 patients . Second, concerns
about the accuracy and reproducibility of the evaluation of
the magnitude of transmural integrated backscatter varia-
tions have been raised by the Iowa group by investigating the
reproducibility of measurements for the entire process of
data acquisition, including transducer placement and
echocardiographic instrument adjustment, as well as longi-
tudinal reproducibility (46). The variance between measure-
ments should be reduced by increasing the number of
independent samples of backscatter making up each mea-
surement. Thus, the use of M-mode rather than two-
dimensional imaging and the use of a relatively small area of
interest were factors that could possibly reduce the repro-
ducibility and reliability of the integrated backscatter mea-
sures. In addition, translational and rotational movements of
the heart should affect the integrated backscatter measures .
Thus, intraobserver and interobserver reproducibility were
evaluated in this study . Our data showed that any of our
integrated backscatter measures, including regional (endo-
cardial and epicardial) measures, could be obtained as
reliably and reproducibly as those in many earlier studies
JACC Vol . 14, No
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(28,44,47,48 . Thus, the mean values of the transmural
difference (or gradient) in integrated backscatter of 5 dB in
patients with hypertrophic cardiomyopathy cannot be ex-
plained solely by the error due to possible problems with
respect to the accuracy and reproducibility of ultrasound
backscatter measurements .
Third, all quantitative analysis was based on the inte-
grated backscatter values determined by hand tracing the
area of interest on the integrated backscatter image, and
there are problems inherent in the measurements (28,40,47) .
Thick, bright echo lines of the right or left septal endocar-
dium, intramyocardial septal specular bright echoes or both
may have affected the integrated backscatter measures in
some patients . The depth of the area of interest was 5 trim in
both normal subjects and patients with hypertrophy, and the
thick bright lines of septal endocardium prevented us from
tracing the midportion of the septum, particularly in normal
subjects with a relatively thin wall . Although this is likely to
lead to a reduced signal-to-noise ratio or an increase in the
integrated backscatter value not related to changes in the
acoustic properties of the myocardium, our current system is
capable of eliminating far stronger signals from the compu-
tation of integrated backscatter . Thus, the effects of the thick
bright lines of septal endocardium and intramyocardial spec-
ular bright echoes were minimized in our current system .
Finally, ultrasound backscatter is affected by the orientation
of myocardial fibers and therefore is view dependent (49,50) .
Thus, our transmural as well as regional evaluation of
integrated backscatter can be performed only in the limited
region of the septum and posterior wall imaged in the
parasternal views . Although our methods cannot be used to
assess noninvasively the extent of abnormal acoustic prop-
erties of the myocardium, the most frequent site of hyper-
trophy is the septum, and this cannot be considered a serious
limitation of the present study .
Clinical implications and conclusions. This study showed
clearly that an analysis of the transmural trend of the
myocardial integrated backscatter may be useful in distin-
guishing between hypertrophic cardiomyopathy and ventric-
ular hypertrophy due to hypertension. Hypertrophic cardio-
myopathy, in most cases, is characterized by asymmetric
septal hypertrophy (3-6,51), and thus conventional echocar-
diography is useful in both the quantification of hypertrophy
and the differentiation of this disease from pressure overload
hypertrophy. The difference between these two types of
hypertrophy in the adult, however, is identified most clearly
by histologic analysis, with myocyte disarray observed
mostly in the septum in hypertrophic cardiomyopathy and
myocardial fibrosis observed in both conditions . Because the
transmural trend of myocardial integrated backscatter was
observed exclusively in patients with hypertrophic cardio-
myopathy, this tissue characterization measure appears to
provide a promising noninvasive method for assessing the
difference between hypertrophic cardiomyopathy and ven-
tricular hypertrophy due to hypertension . Although hyper-
trophic cardiomyopathy and ventricular hypertrophy due to
NAITO ET
AL.
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hypertension may be considered separate entities, their
association continues to be a topic of debate (52) . The use of
myocardial ultrasound tissue characterization may allow
practitioners to gain further insight into this issue .
Differentiation of cardiomyopathy from ventricular hy-
pertrophy due to hypertension was accomplished with the
use of the endocardiallepicardial ratio of myocardial inte-
grated backscatter. It has been noted that this determination
does not need a calibration method because myocardial
integrated backscatter in the halves of the wall determined
with a relative scale may be used for this calculation . As long
as the scale is the same, the endocardial/epicardial ratio is
determined properly,
We thank Akira Shiha, MS, Keiichi Murakami, MS, and Takaki Shimura,
MS, of Fujitsu Laboratory Corporation for advice and modification of the
equipment .
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